GlassScriptPhysician profile
Catherine Callahan
NPI 1083159917
$3,859.45
in general payments reported to CMS, 2019-2025
19 companies · $81.08 in 2025
The $81.08 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $525 · 2022: $1,089 · 2023: $1,391 · 2024: $773 · 2025: $81.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,245.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $875.18 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $825.20 | 2021-2025 | |
| Myovant Sciences INC. | $632.62 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $364.07 | 2021-2023 | |
| Axonics, INC. | $348.23 | 2022-2024 | Axonics |
| Medtronic, INC. | $185.16 | 2022-2024 | Interstim |
| Exeltis, USA INC. | $143.66 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $99.66 | 2023-2024 | Veozah |
| Ascend Therapeutics US, LLC | $60.05 | 2023-2024 | |
| Coloplast Corp | $59.37 | 2023-2024 | Altis |
| Convatec INC. | $52.47 | 2024 | |
| Millicent US INC | $50.28 | 2023-2025 | Intrarosa |
| Allergan, INC. | $39.54 | 2021 | |
| Janssen Biotech, INC. | $25.55 | 2022 | |
| Hologic Sales and Service, LLC | $22.31 | 2023 | Omni Hysteroscope, Novasure, Myosure Tissue Removal Device |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $22.04 | 2022 | |
| Davol INC. | $19.51 | 2024 | Arista Ah Flexitip |
| Exact Sciences Corporation | $18.19 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $16.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Callahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.